← All Startups
Mxt Biotech Series A
Microfluidic platforms for cell engineering and immunotherapies
Mxt Biotech is a biotechnology company that develops transformative microfluidic platforms for cell engineering and immunotherapies.
Location
South Korea
Stage
Series A
Website
mxtbiotech.com
LinkedIn
View profile
BiotechnologyHealth CareMedical
Founders
A
Aram Chung, PhD ’11
LinkedIn
Similar Startups
OpenEvidence Series D
Organizing the world’s medical knowledge
Zachary Ziegler ’17, ,
Centivax
Broad-spectrum vaccine
Stephanie Wisner ’16, ,
Patientory
Web3 for health data
Chrissa McFarlane ’11, ,
Latent Series A
Medical language models for healthcare overhead
Rishabh Jain ’17, ,
SimpliFed Series A
Baby breastfeeding virtual care
Andrea Ippolito ’06, MEng ’07, ,
ModMed
Software for specialty medical practices
Daniel Cane ’98, ,